{"acquisitions":[],"changes":[],"country":"BE","description":"Sequana Medical develops implantable systems to treat drug-resistant fluid overload in liver disease, heart failure, and cancer. It serves patients with conditions like recurrent ascites from cirrhosis and their clinicians. Its FDA-approved alfapump automatically moves built-up abdominal fluid into the bladder for natural elimination.","domain":"sequana.com","employees":null,"founded":2008,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"unknown","industrySources":[],"investors":[],"lat":51.053829,"lng":3.725012,"location":"Ghent, Belgium","multiples":[],"name":"Sequana Medical","people":[],"revenues":[],"rounds":[{"amountQuarantined":false,"amountUsd":25920000,"connectionsAmong":[],"currency":"EUR","date":"2025-03-01","investments":[],"investors":[],"leadInvestor":null,"leadInvestors":[],"people":[],"slug":"sequana-com-2025-03-01-equity","source":{"fact":"round","publisher":"sifted","retrievedAt":"2026-05-07","status":"attributed","url":null},"status":"attributed","type":"seed","url":null}],"slug":"sequana-com","sources":[{"fact":"round","publisher":"sifted","retrievedAt":"2026-05-07","status":"attributed","url":null},{"fact":"existence","publisher":"sequana.com","retrievedAt":"2026-05-07","status":"self-reported","url":"https://sequana.com"},{"fact":"description","publisher":"sequana.com","retrievedAt":"2026-05-07","status":"self-reported","url":"https://sequana.com"}],"stage":"series-b+","stockCard":{"asOf":"2026-11-09","facts":[],"generatedAt":"2026-11-09","state":"insufficient-evidence","tldr":[]},"techStack":[],"totalRaisedUsd":108000000,"traction":[],"updatedAt":"2026-05-07","valuations":[]}